Prediction of basal glycaemia dynamics during treatment with 6-month lipid-lowering therapy in patients at high risk of cardiovascular disease
Background. A major meta-analysis has confirmed the ability of statins to exert both diabetogenic and hyperglycaemic effects. To date, practical recommendations for predicting glucose dynamics during lipid-lowering therapy have not been developed. Aims. Identify the combination of factors that can p...
Saved in:
| Main Authors: | Olga A. Koshelskaya, Anastasiya S. Sushkova, Olga A. Zhuravleva, Irina V. Vinnizkaya, Nataliya G. Brazovskaya, Elena S. Kravchenko, Tatyana E. Suslova, Rostislav S. Karpov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2017-12-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/8633 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ezetimibe potential in cardiology practice
by: A. A. Lyakishev, et al.
Published: (1970-01-01) -
Combined hypolipidemic therapy in patients who failed to achieve target values of the lipidogram. Possibilities of ezetimibe
by: N. V. Fedorova, et al.
Published: (2021-06-01) -
Clinical Outcomes of Ezetimibe Plus Statins in Patients With Lower Extremity Artery Disease
by: Yoshihiro Iwasaki, MD, PhD, et al.
Published: (2025-09-01) -
Combination of statin and ezetimibe in the post-infarction period
by: Valentin E. Oleynikov, et al.
Published: (2024-12-01) -
ESCADRA: a randomised study. Part I: lipid-lowering effectiveness, safety and tolerability of ezetimibe, initial doses of original statins, and the combination of ezetimibe with initial doses of statins in patients with coronary heart disease and hyperlipidemia
by: M. Yu. Zubareva, et al.
Published: (2010-12-01)